Picture the scenario: the development team validates 3D-printed prototypes, machined samples fit, the customer approves and production tooling is released. Three months later, first production batches arrive and parts are rejected. The root cause is usually the same: geometric validation was mistaken for real injection-process validation.
The real issue: material behaviour matters
3D printing and CNC machining are excellent tools for early development. But neither replicates the behaviour of an injection-moulded part in final resin. In industrial projects, that gap is critical.
- The dimensional shrinkage of injected PA66 GF30 cannot be reproduced with photopolymer resin prototypes.
- Internal stresses generated during the injection cycle affect mechanical performance and dimensional stability.
- Assembly tolerances that look valid on machined samples can move out of range in real injection production.
The solution: validate with final material before production tooling
The phase most teams skip under time or budget pressure is often the one that removes the most risk: validation with an industrialisable prototype mould and final polymer. Parts are produced through real injection, transferable process parameters are documented and functional performance is confirmed on real parts.
When production tooling starts, the process window, real shrinkage and CTQ criteria are already known for that specific geometry.
What is the cost of skipping it?
A production mould modification can range from €3,000 to well above €30,000, without counting launch delays and non-conforming parts. Compared to that, early validation with a prototype mould often pays for itself in the first project.
Key decision point: before approving production tooling, the key question is not only whether geometry fits, but whether performance has been validated in final material under real injection conditions.
The question that prevents expensive surprises
Before production tooling kick-off, teams should answer this clearly: have we validated this part in final material, under real injection conditions?
If the answer is no, the risk has already been accepted and will likely surface at the most expensive stage of the project.